Brought to you by 
GSK forms leading consumer health JV with Novartis; later GSK buys out stake
27 Mar 2018
Executive Summary
Creating what Deutsche Bank analysts say will be the top OTC business in the world, GlaxoSmithKline PLC and Novartis AG formed a consumer health joint venture. Ownership will be split 63.5% GSK/36.5% Novartis, with the JV operating under GSK’s GlaxoSmithKline Consumer Healthcare division.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Nutraceuticals
- OTC, Consumer
Deal Status
- Final
Deal Type
-
Alliance
- Joint Venture
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
GSK forms leading consumer health JV with Novartis; later GSK buys out stake
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice